Literature DB >> 15190447

[Pancreatic tail tumor as an unusual first manifestation of Wegener's disease].

S U Christl1, F Borchard, R Keller, R Engemann, W Fischbach.   

Abstract

A fifty-year-old, previously healthy woman presented with abdominal pain and weight loss. Diagnostic work-up revealed a mass in the tail of the pancreas with the appearance of a pancreatic carcinoma. Partial pancreatectomy was performed. Postoperatively, the patient's kidney function deteriorated. Pathohistological examination of the resected tissue showed a granulomatous vasculitis but no maligant tumor. Renal biopsy revealed a rapid progressive glomerulonephritis. Positive C-ANCA screening confirmed the diagnosis of Wegener's disease and an immunosuppressive therapy was established. This case demonstrates the difficult management of a potentially benign pancreatic mass, as reliable discrimination from pancreatic adenocarcinoma is not always possible.

Entities:  

Mesh:

Year:  2004        PMID: 15190447     DOI: 10.1055/s-2004-813113

Source DB:  PubMed          Journal:  Z Gastroenterol        ISSN: 0044-2771            Impact factor:   2.000


  3 in total

Review 1.  Pancreatic granulomatous necrotizing vasculitis: a case report and review of the literature.

Authors:  Ilaria Tinazzi; Paola Caramaschi; Alice Parisi; Niccolò Faccioli; Paola Capelli; Domenico Biasi
Journal:  Rheumatol Int       Date:  2007-01-31       Impact factor: 2.631

Review 2.  Rare type of pancreatitis as the first presentation of anti-neutrophil cytoplasmic antibody-related vasculitis.

Authors:  Tomoya Iida; Takeya Adachi; Tetsuya Tabeya; Suguru Nakagaki; Takashi Yabana; Akira Goto; Yoshihiro Kondo; Kiyoshi Kasai
Journal:  World J Gastroenterol       Date:  2016-02-21       Impact factor: 5.742

3.  Recurrent pancreatic arteritis and vasculogenic relapsing pancreatitis in rheumatoid arthritis - a retrospective clinicopathologic and immunohistochemical study of 161 autopsy patients.

Authors:  Miklós Bély; Agnes Apáthy
Journal:  Pathol Oncol Res       Date:  2008-10-31       Impact factor: 3.201

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.